Stanford Bioengineers Develop "Reverse Translation" Chemistry to Decode Proteins Using Low Cost DNA Sequencers

Stanford bioengineers unveil a "reverse translation" method to sequence proteins using DNA technology, offering 1,000x more sensitivity than mass spectrometry.

By: AXL Media

Published: Mar 18, 2026, 9:46 AM EDT

Source: Information for this report was sourced from Stanford University

Bridging the Technological Gap Between Genomic and Proteomic Sequencing

While the scientific community has spent two decades perfecting high-speed, low-cost DNA sequencing, the ability to sequence proteins has lagged significantly behind. DNA serves as the cellular instruction manual, but proteins are the actual machinery that executes biological functions, folding into the complex shapes that drive immune responses and disease progression. A team led by Stanford professor H. Tom Soh has now introduced a novel approach that effectively runs the natural biological process in reverse. By converting amino acid sequences back into a DNA format, researchers can finally use established genomic infrastructure to decode the proteins that perform the essential work of living cells.

Overcoming the Chemical Complexity of Amino Acid Detection

Sequencing proteins is inherently more difficult than sequencing DNA because proteins are constructed from 20 different amino acids, compared to only four nucleic acid bases in DNA. Furthermore, these amino acids are nearly three times smaller than their DNA counterparts, making them notoriously difficult for traditional sensors to distinguish. The Stanford team addressed this by developing a unique chemistry that tags individual amino acids within a peptide chain using molecule-specific DNA barcodes. This "synthetic DNA" marks the identity and position of each amino acid, creating a readable template that standard sequencing platforms can interpret with unprecedented precision.

Achieving Single Molecule Sensitivity Beyond Mass Spectrometry

The most significant advantage of this new method is its extreme sensitivity compared to current industry standards. Traditional mass spectrometry typically requires a massive sample of one billion to ten billion protein molecules to successfully detect just one million. In contrast, the Stanford technique, led by research engineer Liwei Zheng, can potentially visualize 1,000 times that amount from the same sample size. This leap in sensitivity allows scientists to observe rare proteins that were previously invisible, providing a clearer picture of the cellular diversity that exists even among seemingly identical cells.